Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
---|---|---|---|---|---|---|---|---|
MEMBRANE POTENTIAL | 24.64±1.67 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
MEMBRANE POTENTIAL | human | HepG2 | MMP assay | Negative | IC50 | 163 | ||
MEMBRANE POTENTIAL | 24.08±9.54 | rat | hepatocytes | MMP assay | decrease | IC50 | 163 | |
Pictogram | Signal | Statements | Precautionary Statement Codes |
---|---|---|---|
Danger |
Aggregated GHS information provided by 88 companies from 15 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. H315 (34.09%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (34.09%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H335 (32.95%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure Respiratory tract irritation] H360 (62.5%): May damage fertility or the unborn child [Danger Reproductive toxicity] H373 (61.36%): Causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure] H413 (61.36%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P201, P202, P260, P261, P264, P271, P273, P280, P281, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P314, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) | |
(11b,16b)-21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione | (11beta,16beta)-21-chloro-9-fluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate | 122C467 |
21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione (11beta,16beta)- | 21-Chloro-9-fluoro-11b,17-dihydroxy-16b-methylpregna-1,4-diene-3,20-dione 17-propionate | 21-Chloro-9-fluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate |
21-Chloro-9-fluoro-11beta-hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate | 21-Chloro-9alpha-fluoro-11beta,17alpha-dihydroxy-16beta-methyl-1,4-pregnadiene-3,20-dione 17-Propionate | 21-chloro-9-fluoro-11 beta-hydroxy-16 beta-methylpregna-1,4-diene-3,20-dione 17-propionate |
21-chloro-9-fluoro-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate | 21-chloro-9-fluoro-11ss,17-dihydroxy-16ss-methylpregna-1,4-diene-3,20-dione 17-propionate | 25122-46-7 |
779619577M | AB00383081-10 | AB00383081_11 |
AB1009262 | AC-17990 | AKOS015951278 |
AMOT0927 | AS-12555 | BCP04125 |
BCP0726000094 | BCP9000539 | BDBM39347 |
BRD-K10799896-001-10-6 | BRD-K10799896-001-26-2 | Butavate |
C-22667 | C25H32ClFO5 | CAS-25122-46-7 |
CC-25914 | CCG-220781 | CCI 4725 |
CCI-4725 | CCl 4725 | CGP 9555 |
CGP9555 | CGP9555 pound>> CCl 4725 pound>>CGP 9555 pound>> CCl4725 pound>>CGP-9555 pound>> CCl-4725 | CHEBI:31414 |
CHEMBL1159650 | CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE (EMOLLIENT) |
CPD000058745 | CS-2594 | Certified Reference Material |
Clarelux | Clobesol | Clobestasol propionate |
Clobetasol 17-propionate | Clobetasol Propionate, Pharmaceutical Secondary Standard | Clobetasol for peak identification, European Pharmacopoeia (EP) Reference Standard |
Clobetasol propionate (JP17/USP) | Clobetasol propionate E | Clobetasol propionate [USAN:JAN] |
Clobetasol propionate [USAN:USP:JAN] | Clobetasol propionate gel | Clobetasol propionate, European Pharmacopoeia (EP) Reference Standard |
Clobetasol propionate, United States Pharmacopeia (USP) Reference Standard | Clobetasol propionate, analytical standard | Clobetasolpropionate |
Clobex | Clobex (TN) | Cormax |
Cormax (TN) | D01272 | DB01013 |
DSSTox_CID_25907 | DSSTox_GSID_45907 | DSSTox_RID_81219 |
DTXSID6045907 | Dermoval | Dermovate |
Dermoxinale | EBD6220 | EINECS 246-634-3 |
Embeline | Embeline E | GR 2/925 |
GTPL7062 | HMS2090A04 | HMS2230H08 |
HMS3259A10 | HMS3714M04 | HY-13600 |
Impoyz | LS-118433 | MFCD00058499 |
MLS000028708 | MLS001076345 | NC00551 |
NCGC00023373-03 | NCGC00023373-04 | NCGC00095078-01 |
OLUX FOAM | Olux (TN) | Olux E |
Olux-E | Opera_ID_1470 | Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-beta,17-dihydroxy-16-beta-methyl-, 17-propionate |
Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-beta,17-dihydroxy-16-beta-methyl-,17-propionate; | Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (11beta,16beta)- | Propionic acid clobetasol |
Q421637 | SCHEMBL3997 | SMR000058745 |
SR-01000000280 | SR-01000000280-4 | Temovate |
Temovate E | Tox21_111414 | Tox21_111414_1 |
UNII-779619577M | Yugofin | ZINC3977767 |
[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate | cid_32798 | clobetasol 17-propanoate |
clobetasol-propionate | s2584 |
DrugBank Name | clobetasol propionate |
DrugBank | DB01013 |
CAS Number | 25122-41-2, 25122-46-7 |
PubChem Compound | 32798 |
KEGG Drug | D01272 |
ChEBI | 31414 |